IDEXX LABORATORIES INC /DE financials

  1. Home
  2. Financials
  3. IDXX
IDXX CIK 0000874716

Source: EDGAR filings · Built 2026-06-02T03:17:33Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.06B 808.08M 772.88M 394.15M 636.00M 541.11M
EBITDA 1.51B 1.26B 1.21B 1.01B 1.04B 790.52M
Working Capital 265.01M 331.98M 543.71M -134.33M 192.08M 479.98M
Net Debt 398.15M 448.91M 363.73M 778.89M 813.57M 619.94M
Gross Margin 61.80% 61.04% 59.82% 59.52% 58.76% 58.04%
Operating Margin 31.60% 28.95% 29.97% 26.69% 28.99% 25.66%
Net Margin 24.62% 22.78% 23.08% 20.17% 23.17% 21.49%
Return on Equity (ROE) 65.99% 55.65% 56.92% 111.56% 107.95% 92.04%
Return on Assets (ROA) 31.62% 26.96% 25.92% 24.72% 30.56% 25.35%
Current Ratio 1.23× 1.31× 1.57× 0.89× 1.25× 1.82×
Debt-to-Equity 0.36× 0.46× 0.55× 1.46× 1.39× 1.59×
Effective Tax Rate 19.99% 20.00% 20.37% 21.03% 17.48% 12.06%
Cash Conversion Ratio 1.12× 1.05× 1.07× 0.80× 1.01× 1.11×
Accruals Ratio -0.04× -0.01× -0.02× 0.05× -0.00× -0.03×
SBC % of Revenue 1.39% 1.55% 1.63% 1.48% 1.17% 1.14%
CapEx Coverage 9.48× 7.68× 6.78× 3.65× 6.32× 6.06×
Free Cash Flow Per Share $13.05 $9.71 $9.20 $4.66 $7.35 $6.24

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 51.72× 38.75× 55.17× 50.80× 76.57× 74.50×
P/FCF 51.85× 42.59× 60.31× 87.57× 89.63× 80.11×
FCF Yield 1.93% 2.35% 1.66% 1.14% 1.12% 1.25%
EV / EBITDA 36.09× 27.17× 38.32× 34.23× 54.50× 54.82×
P/S 12.53× 8.66× 12.59× 10.04× 17.32× 15.78×
P/B 33.59× 21.15× 31.04× 55.55× 80.70× 67.58×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 4.30B 3.90B 3.66B 3.37B 3.22B 2.71B
Cost of Goods and Services Sold 1.64B 1.52B 1.47B 1.36B — —
Cost of Revenue — — 1.47B 1.36B 1.33B 1.14B
Gross Profit 2.66B 2.38B 2.19B 2.00B 1.89B 1.57B
Research and Development Expense 251.21M 219.79M 190.95M 254.82M 161.01M 141.25M
Operating Expenses 1.30B 1.25B 1.09B 1.11B — —
Operating Income (Loss) 1.36B 1.13B 1.10B 898.76M 932.03M 694.52M
Income Tax Expense (Benefit) 264.73M 221.96M 216.13M 180.88M 157.81M 79.85M
Net Income (Loss) Attributable to Parent 1.06B 887.87M 845.04M 679.09M 744.85M 581.78M
Earnings Per Share, Basic $13.17 $10.77 $10.17 $8.12 $8.74 $6.82
Weighted Average Number of Shares Outstanding, Basic 80.43M 82.47M 83.07M 83.62M 85.20M 85.34M
Earnings Per Share, Diluted $13.08 $10.67 $10.06 $8.03 $8.60 $6.71
Weighted Average Number of Shares Outstanding, Diluted 81.03M 83.25M 83.98M 84.60M 86.57M 86.72M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 180.07M 288.27M 453.93M 112.55M 144.45M 383.93M
Assets, Current 1.41B 1.40B 1.50B 1.10B 955.65M 1.06B
Assets 3.35B 3.29B 3.26B 2.75B 2.44B 2.29B
Long-term Debt 450.00M 617.80M 698.19M 769.77M 850.71M 909.10M
Liabilities, Current 1.15B 1.07B 951.55M 1.24B 763.58M 582.76M
Long-term Debt, Excluding Current Maturities 374.84M 449.79M 622.88M 694.39M 775.21M 858.49M
Liabilities 1.75B 1.70B 1.78B 2.14B 1.75B 1.66B
Stockholders' Equity Attributable to Parent 1.61B 1.60B 1.48B 608.74M 689.99M 632.09M
Common Stock, Shares, Outstanding 79.71M 81.60M 83.03M 82.89M 84.56M 85.45M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.18B 929.00M 906.51M 542.98M 755.55M 648.06M
Payments to Acquire Property, Plant, and Equipment 124.68M 120.92M 133.63M 148.84M 119.55M 106.96M
Net Cash Provided by (Used in) Investing Activities -136.24M -207.06M -125.25M -195.35M -292.97M -109.38M
Payments for Repurchase of Common Stock 1.22B 837.03M 71.92M 819.71M 746.78M 182.81M
Net Cash Provided by (Used in) Financing Activities -1.16B -878.07M -442.00M -370.94M -697.41M -248.42M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (IDXX CIK 0000874716), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ASMB

ASSEMBLY BIOSCIENCES, INC.

HBT

HBT Financial, Inc.

RC

READY CAPITAL CORPORATION